Patents by Inventor Xiaodong Lin

Xiaodong Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200407365
    Abstract: The invention provides compounds of Formula (I), as described herein, along with stereoisomeric forms salts, hydrates, solvates, and salts thereof and pharmaceutical compositions and pharmaceutical combinations containing such compounds, as well as methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by hepatitis B virus (HBV), and for reducing the occurrence of serious conditions associated with HBV.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 31, 2020
    Inventors: Jiping FU, Rama JAIN, Xianming JIN, Xiaodong LIN, Mika LINDVALL, James R. MANNING, Glenn MCENROE
  • Publication number: 20200276169
    Abstract: This invention pertains generally to antibacterial compounds of Formula I, as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria.
    Type: Application
    Filed: March 19, 2020
    Publication date: September 3, 2020
    Inventors: Virender Singh AULAKH, Anthony CASAREZ, Xiaodong LIN, Mika LINDVALL, Glenn MCENROE, Heinz Ernst MOSER, Folkert RECK, Meiliana TJANDRA, Robert Lowell SIMMONS, Aregahegn YIFRU, Qingming ZHU
  • Patent number: 10597396
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: March 24, 2020
    Assignee: Novartis AG
    Inventors: Anthony Casarez, Markus Furegati, Guido Koch, Xiaodong Lin, Flavio Ossola, Folkert Reck, Robert Lowell Simmons, Qingming Zhu
  • Patent number: 10412083
    Abstract: A plurality of beacons that do not include any service set identifiers may be broadcast from an access point. A request concerning association with the access point may be sent wirelessly from a user device and received at the access point. A unique service set identifier (SSID) for the requesting user device may be generated, and information regarding the unique SSID may be transmitted to the requesting user device. A subsequent association request from the requesting user device may include the unique SSID.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: September 10, 2019
    Assignee: SONICWALL INC.
    Inventors: Guo Hui Zou, Zhong Chen, Zhuangzhi Duo, Xiaodong Lin
  • Patent number: 10381671
    Abstract: The present invention provides a method for removing pentavalent antimony contaminants in water without adding a DC power supply and also provides a fuel cell capable of removing the pentavalent antimony contaminants in water by utilizing self-generated electric energy. A technical solution of the present invention is as follows: waste water is pumped into a reactor for reaction after a pH value of the waste water containing the pentavalent antimony contaminants adjusted to 3-6.5; the inside of a reactor is an anaerobic environment; and an iron anode is arranged in the reactor, a through hole is formed in a side wall of the reactor, a cathode for reducing oxygen by electrons and protons sealed and inlaid in the through hole, and a resistor is connected between the iron anode and the cathode in series. The present invention is suitable for a water treatment technology.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: August 13, 2019
    Assignee: PowerChina Huadong Engineering Corporation Limited
    Inventors: Guowang Zhou, Rujun Tao, Guanglv Yu, Hao Yu, Xiaodong Lin
  • Patent number: 10369138
    Abstract: This invention pertains generally to antibacterial compounds of Formula I, as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: August 6, 2019
    Assignee: Novartis AG
    Inventors: Virender Singh Aulakh, Anthony Casarez, Xiaodong Lin, Mika Lindvall, Glenn McEnroe, Heinz Ernst Moser, Folkert Reck, Meiliana Tjandra, Robert Lowell Simmons, Aregahegn Yifru, Qingming Zhu
  • Publication number: 20190231752
    Abstract: This invention pertains generally to antibacterial compounds of Formula I, as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria.
    Type: Application
    Filed: April 10, 2019
    Publication date: August 1, 2019
    Inventors: Virender Singh AULAKH, Anthony CASAREZ, Xiaodong LIN, Mika LINDVALL, Glenn MCENROE, Heinz Ernst MOSER, Folkert RECK, Meiliana TJANDRA, Robert Lowell SIMMONS, Aregahegn YIFRU, Qingming ZHU
  • Publication number: 20190177324
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Application
    Filed: September 28, 2017
    Publication date: June 13, 2019
    Applicant: Novartis AG
    Inventors: Anthony CASAREZ, Markus FUREGATI, Guido KOCH, Xiaodong LIN, Flavio OSSOLA, Folkert RECK, Robert Lowell SIMMONS, Qingming ZHU
  • Patent number: 10152335
    Abstract: Methods and apparatus relating to seamless host system gesture experience for guest applications on touch based devices are described. In an embodiment, Host Gesture Capture (HGC) logic detects a gesture in response to a touch event. The HGC logic forwards the gesture to Host Gesture Emulator (HGE) logic in response to a determination that the gesture is unrelated to an operation of a host system. The HGE logic operates in accordance with a guest operating system of the host system. Other embodiments are also claimed and described.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: December 11, 2018
    Assignee: Intel Corporation
    Inventors: Yihua Jin, Jianhui Li, Tingtao Li, Xiaodong Lin
  • Patent number: 10065957
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: September 4, 2018
    Assignee: Novartis AG
    Inventors: Anthony Casarez, Markus Furegati, Guido Koch, Xiaodong Lin, Flavio Ossola, Folkert Reck, Robert Lowell Simmons, Qingming Zhu
  • Publication number: 20180167389
    Abstract: A plurality of beacons that do not include any service set identifiers may be broadcast from an access point. A request concerning association with the access point may be sent wirelessly from a user device and received at the access point. A unique service set identifier (SSID) for the requesting user device may be generated, and information regarding the unique SSID may be transmitted to the requesting user device. A subsequent association request from the requesting user device may include the unique SSID.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 14, 2018
    Inventors: Guo Hui Zou, Zhong Chen, Zhuangzhi Duo, Xiaodong Lin
  • Publication number: 20180115005
    Abstract: The present invention provides a method for removing pentavalent antimony contaminants in water without adding a DC power supply and also provides a fuel cell capable of removing the pentavalent antimony contaminants in water by utilizing self-generated electric energy. A technical solution of the present invention is as follows: waste water is pumped into a reactor for reaction after a pH value of the waste water containing the pentavalent antimony contaminants adjusted to 3-6.5; the inside of a reactor is an anaerobic environment; and an iron anode is arranged in the reactor, a through hole is formed in a side wall of the reactor, a cathode for reducing oxygen by electrons and protons sealed and inlaid in the through hole, and a resistor is connected between the iron anode and the cathode in series. The present invention is suitable for a water treatment technology.
    Type: Application
    Filed: June 13, 2017
    Publication date: April 26, 2018
    Inventors: Guowang Zhou, Rujun TAO, Guanglv YU, Hao YU, Xiaodong LIN
  • Publication number: 20180086762
    Abstract: This invention pertains generally to compounds of Formula (A), as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
    Type: Application
    Filed: September 28, 2017
    Publication date: March 29, 2018
    Inventors: Anthony CASAREZ, Markus FUREGATI, Guido KOCH, Xiaodong LIN, Flavio OSSOLA, Folkert RECK, Robert Lowell SIMMONS, Qingming ZHU
  • Patent number: 9843579
    Abstract: A plurality of beacons that do not include any service set identifiers may be broadcast from an access point. A request concerning association with the access point may be sent wirelessly from a user device and received at the access point. A unique service set identifier (SSID) for the requesting user device may be generated, and information regarding the unique SSID may be transmitted to the requesting user device. A subsequent association request from the requesting user device may include the unique SSID.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: December 12, 2017
    Assignee: SONICWALL INC.
    Inventors: Guo Hui Zou, Zhong Chen, Zhuangzhi Duo, Xiaodong Lin
  • Patent number: 9814739
    Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: November 14, 2017
    Assignee: Novartis AG
    Inventors: Sampath-Kumar Anandan, Virender Singh Aulakh, Martijn Fenaux, Xiaodong Lin, Liang Mao, Oliver Saunders, Zachary Kevin Sweeney, Fumiaki Yokokawa, Weidong Zhong
  • Publication number: 20170112868
    Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.
    Type: Application
    Filed: December 14, 2016
    Publication date: April 27, 2017
    Inventors: Sampath-Kumar Anandan, Virender Singh Aulakh, Martijn Fenaux, Xiaodong Lin, Liang Mao, Oliver Saunders, Zachary Kevin Sweeney, Fumiaki Yokokawa, Weidong Zhong
  • Patent number: 9556216
    Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are as defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue fever, yellow fever, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: January 31, 2017
    Assignee: Novartis AG
    Inventors: Sampath-Kumar Anandan, Virender Singh Aulakh, Martijn Fenaux, Xiaodong Lin, Liang Mao, Oliver Saunders, Zachary Kevin Sweeney, Fumiaki Yokokawa, Weidong Zhong
  • Patent number: D863205
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: October 15, 2019
    Inventor: Xiaodong Lin
  • Patent number: D914951
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: March 30, 2021
    Inventor: Xiaodong Lin
  • Patent number: D917772
    Type: Grant
    Filed: January 18, 2021
    Date of Patent: April 27, 2021
    Inventor: Xiaodong Lin